Literature DB >> 2865702

[Ischemic cerebrovascular disease: treatment with various anti-platelet aggregation drugs. Clinical follow-up of 80 patients (22-34 months)].

S Caneschi, C Bonaventi, F Finzi.   

Abstract

Personal experience in the treatment of Ischaemic Cerebrovascular Disease with platelet suppressant drugs is reported. 80 patients were treated with 5 different protocols: 1) group "A": dipyridamol (14 patients); 2) group "B": acetylsalicylic acid (ASA) (14 patients); 3) group "C": dipyridamol and ASA (22 patients); 4) group "D": ditazol (15 patients); 5) group "E": isoxsuprine resinate (15 patients) and followed-up for 22-34 months. The evolution of the disease is discussed and recurrences evaluated on the basis of initial clinical features and particular treatment given.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2865702

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  2 in total

1.  Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Maarten G Lansberg; Martin J O'Donnell; Pooja Khatri; Eddy S Lang; Mai N Nguyen-Huynh; Neil E Schwartz; Frank A Sonnenberg; Sam Schulman; Per Olav Vandvik; Frederick A Spencer; Pablo Alonso-Coello; Gordon H Guyatt; Elie A Akl
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Multiple versus fewer antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attack.

Authors:  Imama A Naqvi; Ayeesha K Kamal; Hasan Rehman
Journal:  Cochrane Database Syst Rev       Date:  2020-08-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.